-transparent.png){kind=logo}
Five patients in the blastic phase of chronic granulocytic leukemia with massive splenomegaly were treated by intraarterial splenic artery infusion of cytosine arabinoside. All patients had massive splenomegaly associated with pain and/or hypersplenism and were refractory to previous therapy. All 5 patients demonstrated responses to treatment, with reduction in spleen size as well as symptomatic relief. Systemic toxicity was minimal in 4 of the 5 patients.
Related Publications
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
January 1986,
Clinical and laboratory haematology,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
January 2015,
Tumori,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
January 1946,
Khirurgiia,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
May 2008,
The American surgeon,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
July 1989,
European journal of haematology,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
February 1963,
Maroc medical,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
November 2007,
Gastroenterologia y hepatologia,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
January 1952,
The Journal of the Egyptian Medical Association,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
January 1915,
Proceedings of the Royal Society of Medicine,
G P Canellos, and
S B Sutliffe, and
V T DeVita, and
T A Lister
January 1915,
Proceedings of the Royal Society of Medicine,
